US court rejects motion to dismiss Bayer haemophilia suit

16-03-2018

A Californian court has rejected a motion to dismiss a lawsuit involving a treatment for haemophilia A, a genetic blood coagulation disorder.


Bayer Healthcare, Nektar Therapeutics, patent infringement, motion to dismiss, blood disorder, Baxalta, biotechnology

LSIPR